CSPC Pharmaceutical Group Limited — Earnings Release 2004

May 31, 2004

Listed Company Information

Listed Company Information
CHINA PHARMA<01093> - Results Announcement (Summary) China Pharmaceutical Group Limited announced on 31/05/2004: (stock code: 01093 ) Year end date: 31/12/2004 Currency: HKD Auditors' Report: N/A (Unaudited ) (Unaudited ) Last Current Corresponding Period Period from 01/01/2004 from 01/01/2003 to 31/03/2004 to 31/03/2003 Note ('000 ) ('000 ) Turnover : 580,597 635,896 Profit/(Loss) from Operations : 102,033 188,024 Finance cost : (4,197) (7,102) Share of Profit/(Loss) of Associates : N/A N/A Share of Profit/(Loss) of Jointly Controlled Entities : 1,268 1,346 Profit/(Loss) after Tax & MI : 84,745 153,827 % Change over Last Period : -45 % EPS/(LPS)-Basic (in dollars) : 0.0551 0.1024 -Diluted (in dollars) : N/A 0.1004 Extraordinary (ETD) Gain/(Loss) : N/A N/A Profit/(Loss) after ETD Items : 84,745 153,827 1st Quarter Dividend : NIL NIL per Share (Specify if with other : N/A N/A options) B/C Dates for 1st Quarter Dividend : N/A Payable Date : N/A B/C Dates for (-) General Meeting : N/A Other Distribution for : N/A Current Period B/C Dates for Other Distribution : N/A Remarks: 1. The accounting policies adopted are consistent with those followed in the preparation of the Group's annual financial statements for the year ended December 31, 2003. 2. The calculation of the basic and diluted earnings per share is based on the following data: Three months ended March 31, 2004 2003 Profit attributable to shareholders HK$84,745,000 HK$153,827,000 ============= ============== Weighted average number of ordinary shares for the purpose of basic earnings per share 1,538,124,661 1,502,212,661 ============ Effect of dilutive potential ordinary shares in respect of share options 29,324,161 --------------- Weighted average number of ordinary shares for the purpose of diluted earnings per share 1,531,536,822 ================